Brief: Catheter Precision To Acquire Assets In Development For Late-Stage Treatment For Acute Decompensated Heart Failure
23/04/2025 13:20
April 23 (Reuters) - Catheter Precision Inc VTAK.A: CATHETER PRECISION TO ACQUIRE ASSETS IN DEVELOPMENT FOR LATE-STAGE TREATMENT FOR ACUTE DECOMPENSATED HEART FAILURE Source text: ID:nGNX885c94 Further company coverage: VTAK.A ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Catheter Precision
See all newsBrief: Catheter Precision Inc - Files For Offering Of Up To 68.1 Million Shares Of Common Stock - SEC Filing
Brief: Catheter Precision - On June 7, Entered Purchase Agreement To Buy 2.94 Million Volato Shares At $0.34 Per Share For $1 Million - SEC Filing
Brief: Catheter Precision Inc Engaged A Strategic Advisor To Formally Market For Sale Its Cardiac Electrophysiology Business
Brief: Catheter Precision Reports 2025 Results And Updates On Strategic Expansion
Catheter Precision falls on sale of artery cleaning device business